Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of CapLease (NYSE: LSE ) , a REIT focused on investing in commercial real estate that is net-leased, soared as much as 23% after agreeing to be acquired by American Realty Capital (NASDAQ: ARCP ) for $2.2 billion.
So what: The deal, which values CapLease at $8.50 a share, follows American Realty's unsuccessful attempt to purchase Cole Credit Property Trust earlier this year and would now make it the third largest company in the net-lease sector. According to American Realty, it expects the deal will add an additional $0.11 per year in funds from operations and plans to boost its dividend by $0.03 to an annualized rate of $0.94 once the deal closes.
Now what: On paper this looks like a great deal for both parties given that the ongoing low interest rate environment is only going to fuel investor interest in these high yielders, and the fact that net-leased properties (those which require the renter to pay additional expenses beyond rent) cost little to maintain. On the flipside, though, I have to admit I'm a bit worried about American Realty taking on $1.2 billion of CapLease's debt. Overall, this could be a net positive for shareholders in both companies, but I'd tread cautiously around American Realty, especially if the Federal Reserve begins to wind down its bond-buying program.
Top 10 Small Cap Stocks For 2015: Stein Mart Inc.(SMRT)
Stein Mart, Inc. operates retail stores that offer fashion merchandise for women and men in the United States. The company?s stores provide fashion apparel, accessories, shoes, and home fashions. As of April 19, 2011, it operated a chain of 263 retail stores. The company was founded in 1908 and is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By CRWE]
Stein Mart, Inc. (Nasdaq:SMRT) reported comparable store sales for the four-week period ended August 25, 2012 increased 5.6 percent. Total sales for the period were $79.0 million, an increase of 6.9 percent from $73.9 million in the same period in 2011.
Best Managed Healthcare Companies To Invest In 2014: Lloyds Banking Group PLC (LYG)
Lloyds Banking Group plc, incorporated on October 21, 1985, is a holding company. The Company is a financial services group providing a range of banking and financial services, primarily in the United Kingdom, to personal and corporate customers. The Company operates in four segments: Retail, Commercial Banking, Wealth, Asset Finance and International and Insurance. Retail provides banking, mortgages and other financial services to personal customers in the United Kingdom. Commercial Banking provides banking and related services to business clients, from small businesses to large corporate. Wealth, Asset Finance and International provides private banking and asset management and asset finance in the United Kingdom and overseas and operates the Company�� international retail businesses. Insurance provides long term savings, protection and investment products in the United Kingdom and Europe and provides general insurance to personal customers in the United Kingdom.
Retail
The Retail division operates the retail bank in the United Kingdom and is a provider of current accounts, savings, personal loans, credit cards and mortgages. This includes a range of current accounts including packaged accounts and basic banking accounts. It is also the provider of personal loans in the United Kingdom, as well as being the United Kingdom�� credit card issuer. Retail is the private sector savings provider in the United Kingdom. It is also a general insurance and bancassurance distributor, offering a range of long-term savings, investment and general insurance products.
Commercial Banking
The Commercial Banking division supports the Company�� business clients from small businesses to corporate. Commercial Banking provides support to corporate clients through the provision of core banking products, such as lending, deposits and transaction banking services whilst also offering clients expertise in capital markets (private placements, bonds and syndicated loans), ! financial markets (foreign exchange, interest rate management, money market and credit) and private equity.
Wealth, Asset Finance and International
Wealth, Asset Finance and International consists of the Company�� the United Kingdom and international wealth businesses, the Company�� the United Kingdom and international asset finance and online deposit businesses along with its international retail businesses. The Wealth business consists of private banking and asset management. Wealth�� private banking operations cater to the range of wealth clients from affluent to Ultra High Net Worth within the United Kingdom, Channel Islands and Isle of Man, and internationally. Asset Finance consists of a number of leasing and speciality lending businesses in the United Kingdom, including Lex Autolease and Black Horse Motor and Personal Finance along with its leasing and specialty lending businesses in Australia and its European online deposit business. The international business comprises its non-core banking business outside the United Kingdom, with the exception of corporate business written through the Commercial Banking division. This primarily consists of Ireland, Retail Europe and Asia.
Insurance
The Insurance division provides long-term savings, protection and investment products and general insurance products to customers in the United Kingdom and Europe. The United Kingdom Life, Pensions and Investments business provides long-term savings, protection and investment products distributed through the bancassurance, intermediary and direct channels of the Lloyds TSB, Halifax, Bank of Scotland and Scottish Widows brands. The European Life, Pensions and Investments business distributes products primarily in the German market under the Heidelberger Leben and Clerical Medical brands. The General Insurance business is a distributor of home insurance in the United Kingdom, with products sold through the branch network, direct channels and strategic corporate! partners! . It operates primarily under the Lloyds TSB, Halifax and Bank of Scotland brands.
Advisors' Opinion:- [By Jeff Reeves]
Swiss financials Credit Suisse (CS) and UBS as well as U.K. banks like Lloyd's (LYG) have delivered returns significantly better than the S&P 500 this year. Optimism regarding consumer and business lending has lifted shares, and the trend looks to continue in 2014. If you're a believer in the EU recovery, financial stocks are a great way to be at the center of an economic turnaround.
- [By Owain Bennallack]
LONDON --�In this investing video, Owain Bennallack reveals why he thinks the Chancellor of the Exchequer should be happy with the recent revival at�Lloyds� (LSE: LLOY ) � (NYSE: LYG ) .
- [By G. A. Chester]
LONDON --�There are things to love and loathe about most companies. Today, I'm going to tell you about three things to love about�Lloyds Banking Group� (LSE: LLOY ) (NYSE: LYG ) .
- [By Andrew Marder]
Barclays fell into the capital shortfall trap along with RBS and Lloyds (NYSE: LYG ) . Lloyds, especially, is going to be watching how smoothly Barclays' new issuance goes. The bank reported stronger than expected earnings last week, and the success has opened up the possibility that the U.K. government may be able to start selling off its stake. The Barclays' issuance could provide a good temperature check of the market, and help move that action along.
Best Managed Healthcare Companies To Invest In 2014: GOFF, CORP. (GOFF)
Goff Corporation, incorporated on July 12, 2010, is a development-stage company. The Company, through its wholly owned subsidiary, Golden Glory Resources S.A., is engaged in mineral exploration. The Company's primary project is the La Frontera Gold Project located in the Aguadas Department, in Caldas, Colombia. The Project is being pursued as a potential bulk-tonnage, gold-silver target. Golden Glory acquired its leases on the La Frontera through a transaction with a Colombian company and holds a 100% working interest in the property. The Company through its subsidiary Golden Glory Resources, focuses on the La Frontera Gold Project covers prospective ground and merits continued gold exploration, including exploration diamond drilling. In April 2013, the Company has established a new, wholly owned subsidiary Golden Glory Resources Colombia SAS.
The La Frontera Project is in the Aguadas, Department Of Caldera, which is located approximately 60 kilometers south of Medellin, Colombia. A NI43-101 report is completed on the La Frontera Property, which identifies the potential for gold in both veins and a porphyry structure on the leases. The LGC-15011 Project (La Frontera Project) is located in the northern department of Caldas, Colombia (LGC-15011 has 30% in Antioquia), in the village of Puente Piedra, in the municipality of Aguadas.
Advisors' Opinion:- [By Brian Richards]
Goff (NASDAQOTCBB: GOFF ) , a social recruiting-company-turned-Colombian-gold miner, did not exist as an incorporated business before the summer of 2010 and did not trade as a public company until March 2013. Yet since its debut on the over-the-counter market, on average it has traded more shares each day than Apple or ExxonMobil.
Best Managed Healthcare Companies To Invest In 2014: Juniper Networks Inc (JNPR)
Juniper Networks, Inc. (Juniper Networks), incorporated on September 10, 1996, designs, develops, and sells products and services that together provide its customers with network infrastructure. It operates in two segments: Infrastructure and Service Layer Technologies (SLT). The Company�� Infrastructure segment primarily offers routing and switching products that are used to control and direct network traffic from the core, through the edge, aggregation, and the customer premise equipment level. Infrastructure products include its Internet protocol (IP) routing, carrier Ethernet routing portfolio, and Ethernet switching portfolio. In addition, the Infrastructure segment offers a complete wireless local area network (WLAN) solution. Its SLT segment offers solutions that meet a range of its customers' priorities, from protecting the users, applications and data on the network itself to providing network services across a distributed infrastructure. Effective September 13, 2013, Juniper Networks, Inc. acquired Contrail Networks Inc.
Brilliant is a supplier of packet-based, network synchronization equipment and monitoring solutions. During the year ended December 31, 2011, the Company introduced its network architecture and fabric technology for the data center, QFabric. It serves the high-performance networking requirements of global service providers, enterprises, and public sector organizations. The Company�� open cross-network software platform includes the Junos operating system (Junos OS), Junos Space network application platform, and Junos Pulse integrated network client. The Company offers a product portfolio that spans routing, switching, security, application access, and mobility device security.
Infrastructure Products
The Company�� T Series core routers are primarily designed for core IP infrastructures and are also being sold into the multi-service environment. Its PTX Series is a large capacity (8 and 16 tera-bits per second) MPLS-optimized packe! t transport switch for the core networks, of content service providers and Tier 1 service providers, with high throughout of packet traffic. The Company�� E Series products are a full featured platform designed for the network edge with support for carrier-class routing, broadband subscriber management services, and a set of IP services. The MX Series is a product family developed to address emerging Ethernet network architectures and services in service provider and enterprise networks. The Company�� EX Series family extends its product portfolio running its Junos OS to address the Ethernet switch market. Ethernet is a used technology, which is used to transport information in enterprise networks. Infrastructure Products also includes QFabric Products and WLAN product.
SLT Products
SLT Products include Services Gateway, Integrated Firewall, and VPN Solutions, Secure Access Appliances, Secure Access Appliances, IDP Series Appliances and Identity and Policy Control Solutions. The Company�� SRX Series of dynamic services gateways, running its Junos software, provides firewall/VPN and combines routing, switching, and security functionality. The series is designed to meet network and security requirements for data center consolidation, rapid managed services deployments, and aggregation of security services. Its firewall and VPN systems and appliances are designed to provide integrated firewall, VPN, and denial of service protection capabilities for both enterprise environments and service provider network infrastructures. These products range from its SSG product series, which combines LAN/WAN routing capabilities with threat management features, such as antivirus, anti-spam, and Web filtering technologies, to its ISG and NetScreen Series firewall and VPN systems, which are designed to deliver security in medium/large enterprises, carrier networks, and data centers.
The Company�� Junos Pulse, Junos Pulse Mobile Security Suite, and SA Series SSL VPN appliances,! designed! for use in companies of all sizes, are used to provide secure access to corporate resources for remote and mobile users from any Web-enabled device, regardless of location. Its portfolio of identity and policy control solutions integrates subscriber privileges, application requirements, and business policies with the IP network infrastructure.
The Company competes with Cisco Systems, Inc. (Cisco), Alcatel-Lucent, Brocade Communications Systems, Inc. (Brocade), Extreme Networks, Inc., Hewlett Packard Company (HP), Huawei Technologies Co., Ltd. (Huawei), Check Point Software Technologies, F5 Networks, Inc., Palo Alto Networks, Inc., and Riverbed Technology, Inc.
Advisors' Opinion:- [By Jonas Elmerraji]
2014 has been a rough year for shareholders in Juniper Networks (JNPR). Since shares peaked in January, this stock has dropped to the tune of 17%. The bad news is that this stock isn't showing any signs of ending that selloff. The good news is that you don't have to be an expert technical trader to figure out what's going on here.
The price action in Juniper Networks is about as simple as it gets. JNPR has been bouncing its way lower in a textbook downtrending channel since last September, swatted lower on each successive test of trend line resistance. That pair of parallel trend lines on Juniper's chart defined the high-probability range for shares of JNPR to trade within. And since those lines are pointing down and to the right, it makes sense to stay out of this stock in August. It's really just as simple as that.
I'd recommend staying away from the long-side of JNPR until shares can press up through their 50-day moving average, a level that's been a good proxy for trend line resistance on the way down. Until that happens, the downtrend is intact.
Read More: 5 Hated Earnings Stocks You Should Love
- [By Jayson Derrick]
A mistrial has been declared in Juniper Networks' (NASDAQ: JNPR) infringement suit against Palo Alto Networks (NADAQ: PANW) Shares of Juniper lost 0.64 percent, closing at $26.27 while Palo Alto surged 10.90 percent, closing at $77.02.
- [By Jake L'Ecuyer]
Equities Trading UP
Juniper Networks (NYSE: JNPR) shot up 7.77 percent to $28.03 after the company reported better-than-expected fourth-quarter results. Barclays upgraded the stock from Equalweight to Overweight and lifted the price target from $29.00 to $34.00.
Best Managed Healthcare Companies To Invest In 2014: Enzymotec Ltd (ENZY)
Enzymotec Ltd., incorporated on March 08, 1998, is engaged in manufacturing of ingredients and medical foods company. Its technologies, research, and clinical validation process enables the Company to develop differentiated solutions across a variety of products. The Company markets its product portfolio primarily to established global consumer companies and target large and growing consumer health and wellness markets. Its clinically validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases. The Company operates in two segments: Nutrition and VAYA Pharma. In addition to its existing products, the Company has several other products to address additional indications in the development phase. enzyme processes; lipid modification; lipid analysis; and process technology and development.
Nutrition
The Company�� Nutrition segment develops and manufactures nutritional ingredient products based on lipids, such as phospholipids, which form the structural basis of cell membranes and are easily recognized, incorporated and used by the body. Its customer base for this segment includes formula and nutritional supplement companies such as Biostime and IVC. Its two selling nutritional ingredient products are InFat, a clinically-proven fat ingredient for infant formula, and krill oil. Its other products in this segment are targeted at improving brain health and providing benefits in memory, learning abilities and concentration.
VAYA Pharma
VAYA Pharma, develops, manufactures and sells branded, prescription-only medical foods for the dietary management of patients with certain medical conditions or diseases having special, medically determined nutrient requirements. Although medical foods must be safe and effective as demonstrated in human clinical studies, they do not require the same expensive and time consuming regulatory approval process typical of prescription drugs. In addition to! its existing products, it has several other products to address additional indications in the development phase.
Advisors' Opinion:- [By Victor Selva]
Finally, as opposed to what we just discussed, the firm is currently Zacks Rank # 4��ell, and it also has a longer-term recommendation of ��eutral�� A Sell rating indicates that the stock, over the next 1 to 3 months, will perform at an annualized rate of 4.8%, which is not attractive for investors. For investors looking for a Strong Buy Rank, BioLife Solutions, Inc. (BLFS) and Enzymotec Ltd. (ENZY) could be the options.
Best Managed Healthcare Companies To Invest In 2014: Senesco Technologies Inc (SNTI)
Senesco Technologies, Inc., incorporated on September 30. 1999, is engaged in utilize its eukaryotic translation initiation Factor 5A, or Factor 5A, and deoxyhypusine synthase (DHS), and related technologies for human therapeutic applications to develop approaches to treat cancer and inflammatory diseases. In agricultural applications, the Company has licensed applications of the Factor 5A, DHS and Lipase platforms to develop the productivity of fruits, flowers, vegetables, agronomic and biofuel feedstock crops through the control of cell death and growth in plants.
Human Therapeutic Applications
The Company has developed a therapeutic candidate, SNS01-T, an improved formulation of SNS01, for the potential treatment of multiple myeloma and non-Hodgkin B-cell lymplomas. SNS01-T utilizes the Company's Factor 5A technology and consists of two components, which include a DNA plasmid (pDNA), expressing human eIF5A containing a lysine to arginine substitution at amino acid position 50, (eIF5AK50R), and a small inhibitory RNA (siRNA). These two components are combined in a fixed ratio with a polymer, polyethyleneimine (PEI), which enables self-assembly of the DNA and RNA into nanoparticles with demonstrated enhanced delivery to tissues and protection from degradation in the blood stream. The Company has also demonstrated that the combination of lenalidomide and SNS 01-T performs better than either treatment alone in mouses xenograft models of human mantle cell lymphoma. The Company's human therapeutic research program, which consists of pre-clinical in-vitro and in-vivo experiments designed to assess the role and mode of action of Factor 5A in human diseases and a phase 1a/2b clinical trial.
The Company competes with Celgene, Inc., Takeda/Millennium, ONYX Pharmaceuticals, Inc., Amgen Inc., Janssen Biotech, Inc., Novartis AG, and Pharmacyclics, Inc.
Agricultural Applications
The Company's agricultural research focuses on the discovery and develo! pment of certain gene technologies, which are designed to confer positive traits on fruits, flowers, vegetables, forestry species and agronomic crops. The Company's research and development initiatives for agriculture include develop and implement the DHS and Factor 5A gene technology in banana, canola, cotton, turfgrass, rice, alfalfa, corn, soybean and trees; and test the resultant crops for new beneficial traits such as increased yield, increased tolerance to environmental stress, disease resistance and more efficient use of fertilizer.
The Company competes with Mendel Biotechnology, Renessen LLC, Exelixis Plant Sciences, Inc., and Syngenta International AG.
Advisors' Opinion:- [By CRWE]
Today, SNTI has shed (-2.44%) down -0.0010 at $.0400 with�723,673 shares in play thus far (ref. google finance Delayed: 2:58PM EDT October 7, 2013).
Senesco Technologies, Inc. previously reported it has entered into a securities purchase agreement with certain investors to raise $1.725 million in gross proceeds through the sale of 69,000,000 shares of its common stock. The common stock was priced at $0.025 per share.
The offering is expected to close on or about October 2, 2013, subject to customary closing conditions. The net proceeds of the financing will be used primarily for working capital, research and development and general corporate purposes.
- [By Peter Graham]
At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards ��ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it�� a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:
No comments:
Post a Comment